Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

A large‐scale exome array analysis of venous thromboembolism

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      University of Washington Seattle; Fred Hutchinson Cancer Research Center Seattle (FHCRC); Harvard T.H. Chan School of Public Health; Bordeaux population health (BPH); Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM); Rady Children's Hospital; University of California San Diego (UC San Diego); University of California (UC); The Arctic University of Norway Tromsø, Norway (UiT); Framingham Heart Study; Boston University Boston (BU)-National Heart, Lung, and Blood Institute Bethesda (NHLBI); Boston University Boston (BU); Brigham and Women’s Hospital Boston, MA; Harvard Medical School Boston (HMS); University of Minnesota MN, USA; Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN); Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition CHU Pitié Salpêtrière (IHU ICAN); CHU Pitié-Salpêtrière AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU); Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition CHU Pitié Salpêtrière (IHU ICAN); Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU); Hôpital de la Timone CHU - APHM (TIMONE); Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN); Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE); Centre de ressources biologiques Tissus ADN Cellules Hôpital de la Timone - APHM (CRB TAC); Département de génétique médicale Hôpital de la Timone - APHM; Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Timone CHU - APHM (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Timone CHU - APHM (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM); Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)); Hôpital Européen Georges Pompidou APHP (HEGP); Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité); Centre National de Recherche en Génomique Humaine (CNRGH); Institut de Biologie François JACOB (JACOB); Direction de Recherche Fondamentale (CEA) (DRF (CEA)); Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)); Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA); Ohio State University Columbus (OSU); University Hospital of North Norway Tromsø (UNN); Boston Veterans Administration Healthcare System; West Roxbury; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO); Kaiser Permanente Washington Health Research Institute Seattle (KPWHRI); Los Angeles Biomedical Research Institute (LA BioMed); Seattle Epidemiologic Research and Information Center Seattle; Massachusetts General Hospital Boston; ANR-10-IAHU,ANR-10-LABX-0013,DK063491,R01HL116854,HL74745,R01HL35464,HL060739,HHSN268200800007C,HHSN268201700003I,N01HC55222,N01HC85083,N01-HC-25195,N01HC85079, HL080467, R01AG023629,HL59367,N01HC85086,HL053375,HHSN268201200036C,HL068986,HL095080,R01HL034594,R01HL088521,HHSN268201800001C HL68639 R01HL103612 HL043201 R01HL087652 R01HL130114 P01CA055075 HL099355 R01HL105756 HHSN268201600004C R01CA50385 HHSN268201700002I R01HL068986 HHSN268201700005I HHSN268201700001I N01HC85081 HHSN268201600002C N01HC85080 HHSN268201600003C HL040628; ANR-10-LABX-0013,GENMED,Medical Genomics(2010); ANR-10-IAHU-0003,Méditerranée Infection,I.H.U. Méditerranée Infection(2010)
    • بيانات النشر:
      HAL CCSD
      Wiley
    • الموضوع:
      2019
    • Collection:
      HAL-CEA (Commissariat à l'énergie atomique et aux énergies alternatives)
    • نبذة مختصرة :
      International audience ; Although recent Genome-Wide Association Studies have identified novel associations for common variants, there has been no comprehensive exome-wide search for low-frequency variants that affect the risk of venous thromboembolism (VTE). We conducted a meta-analysis of 11 studies comprising 8,332 cases and 16,087 controls of European ancestry and 382 cases and 1,476 controls of African American ancestry genotyped with the Illumina HumanExome BeadChip. We used the seqMeta package in R to conduct single variant and gene-based rare variant tests. In the single variant analysis, we limited our analysis to the 64,794 variants with at least 40 minor alleles across studies (minor allele frequency [MAF] similar to 0.08%). We confirmed associations with previously identified VTE loci, including ABO, F5, F11, and FGA. After adjusting for multiple testing, we observed no novel significant findings in single variant or gene-based analysis. Given our sample size, we had greater than 80% power to detect minimum odds ratios greater than 1.5 and 1.8 for a single variant with MAF of 0.01 and 0.005, respectively. Larger studies and sequence data may be needed to identify novel low-frequency and rare variants associated with VTE risk.
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/30659681; hal-02544372; https://amu.hal.science/hal-02544372; https://amu.hal.science/hal-02544372/document; https://amu.hal.science/hal-02544372/file/nihms-1004340.pdf; PRODINRA: 478752; PUBMED: 30659681; PUBMEDCENTRAL: PMC6520188; WOS: 000474078900008
    • الرقم المعرف:
      10.1002/gepi.22187
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.5344D32A